logo
logo

Fog Pharmaceuticals announced it raised $178 Million in an initial filing from an offering of $178 Million

Dec 02, 2022over 2 years ago

Amount Raised

$178 Million

CambridgeBiotechnologyHealth CareTherapeuticsPharmaceutical

Company Information

Company

FogPharma

Location

30 ACORN PARK DRIVE

Cambridge, Massachusetts, United States

About

FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability. The company is pioneering the discovery, development and commercialization of HeliconTM peptides, a new drug modality that uniquely combines the broad targeting power of monoclonal antibodies with the cell-penetrating ability of small molecules. HeliconTM peptides hold the promise, not only to drug nearly all human disease drivers, but also to do so with unrivaled speed and scalability.

FundzWatch™ Score

62
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People